Suppr超能文献

儿童未分类的炎症性肠病:诊断与药物治疗

Inflammatory Bowel Disease-Unclassified in Children: Diagnosis and Pharmacological Management.

作者信息

D'Arcangelo Giulia, Aloi Marina

机构信息

Department of Pediatrics, Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.

出版信息

Paediatr Drugs. 2017 Apr;19(2):113-120. doi: 10.1007/s40272-017-0213-9.

Abstract

Inflammatory bowel diseases are chronic disorders of the gastrointestinal tract that include Crohn's disease (CD), ulcerative colitis (UC) and inflammatory bowel disease-unclassified (IBDU). The latter defines a subgroup of patients with clinical and endoscopic evidence of chronic colitis, without specific features of either CD or UC. These patients will possibly be re-classified as having UC or CD during the follow-up, although a significant percentage of them will keep the diagnosis of IBDU. IBDU is the rarest subtype of IBD, both in children and in adults, although it is twice as common among the pediatric population, especially in the younger ages. The diagnosis can only be made after a comprehensive diagnostic work-up, combining clinical history, physical and laboratory examination, upper and lower gastrointestinal endoscopy, with histology and imaging of the small bowel. The therapeutic strategy is borrowed from that of UC and CD, although recent data suggest that IBDU has a lower therapeutic burden with a generally mild disease course and a good response to mesalamine. Since there are only few published data on pediatric IBDU, and no guidelines on its management are available, this review aims at summarizing the most recent evidence for the diagnostic work-up with a specific focus on medical and surgical options in the treatment of IBDU.

摘要

炎症性肠病是胃肠道的慢性疾病,包括克罗恩病(CD)、溃疡性结肠炎(UC)和未分类的炎症性肠病(IBDU)。后者定义了一组具有慢性结肠炎临床和内镜证据,但无CD或UC特异性特征的患者。这些患者在随访期间可能会被重新分类为患有UC或CD,尽管其中相当一部分患者将维持IBDU的诊断。IBDU是IBD最罕见的亚型,在儿童和成人中均如此,尽管在儿科人群中更为常见,尤其是在较小年龄段。只有在综合诊断评估后才能做出诊断,综合评估包括临床病史、体格检查和实验室检查、上下消化道内镜检查以及小肠组织学和影像学检查。治疗策略借鉴了UC和CD的治疗策略,尽管最近的数据表明,IBDU的治疗负担较低,疾病进程通常较轻,对美沙拉嗪反应良好。由于关于儿科IBDU的已发表数据很少,且尚无关于其管理的指南,本综述旨在总结诊断评估的最新证据,特别关注IBDU治疗中的内科和外科选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验